RCCA New Jersey physicians honored to be named Castle Connolly Top Cancer Doctors 2024

Combined with a uniquely personal approach, cutting-edge therapies and sophisticated diagnostics, physicians at Regional Cancer Care Associates’ 16 New Jersey locations deliver state-of-the-art care in an environment that is supportive and hopeful.

Importantly, RCCA is able to deliver this care close to a patient’s home, easing the burden for those who would rather not travel to New York or Philadelphia. Loved ones can instead focus on providing support and strength, while patients can focus on healing. Additionally, a Journal of Clinical Oncology showed that receiving cancer care close to home reduces hospitalizations.

The physicians named to Castle Connolly’s prestigious list of 2024 Top Cancer Doctors in New Jersey are:

• May Abdo-Matkiwsky DO, serving the Sparta community
• Kaleem Ahmad, MD, serving the Cape May and Marmora communities
• Seth Berk, MD, serving the Moorestown community
• Maurice Cairoli, MD, serving the Moorestown community
• Jumana Chatiwala, MD, serving the Sparta community
• Michele Donato, MD, serving the Hackensack community
• Denis Fitzgerald, MD, serving the Little Silver community
• Loren Godfrey, MD, serving the Hackensack community
• Andre Goy, MD, serving the Hackensack community
• Harry Harper, MD, serving the Hackensack community
• Mira Hellmann, MD, serving the Hackensack community
• Anthony Ingenito, MD, serving the Hackensack community
• Merieme Klobocista, MD, serving the Hackensack community
• James Lee, MD, serving the Moorestown community
• Brett Lewis, MD, serving the Hackensack community
• Mark Pascal, MD, serving the Hackensack community
• Andrew Pecora, MD, serving the Hackensack community
• Stanley Waintraub, MD, serving the Hackensack community
• Stephen Wallace, MD, serving the Moorestown community

Of the 850,000 practicing physicians in the U.S., just 7% are named to the Top Doctors list. The recognition is given following a comprehensive review process conducted by an experienced medical review board. Reviewers consider a doctor’s skills, professionalism, training/qualifications, experience, competence, outcomes and achievements as well as his or her relational skills and empathy toward patients.

RCCA has more than 90 cancer specialists who treat patients at more than 20 RCCA care centers in New Jersey, Connecticut, Maryland and the Washington, D.C., area. Those oncologists see more than 23,000 new patients each year and provide care to more than 225,000 established patients, collaborating closely with their patients’ other physicians.

RCCA is the top choice of many patients due to the comprehensive services offered by its physicians, including immunotherapies and targeted therapy. Patients also have access to a range of clinical trials. In addition to serving patients who have solid tumors, blood-based cancers, and benign blood disorders such as anemia, RCCA care centers also provide infusion services to people with a number of non-oncologic conditions — including multiple sclerosis, Crohn’s disease, asthma, and rheumatoid arthritis — who take intravenously administered medications.

To learn more about RCCA, call 844-928-0089 or visit RCCA.com.